March 21st 2024
Office-based surgery could prove to be a viable option for physicians.
Medical Crossfire®: Expert Perspectives in Geographic Atrophy – How Can We Prepare for a New Era of Treatment?
View More
(CME Credit) Addressing Healthcare Inequities Diabetic Retinal Vascular Disease: How Can We Address Ethnic Disparities within the Clinic?
View More
(COPE Credit) Addressing Healthcare Inequities Diabetic Retinal Vascular Disease: How Can We Address Ethnic Disparities within the Clinic?
View More
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
View More
(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
18th Annual Controversies in Modern Eye Care
May 4, 2024
Register Now!
Headed to ARVO? You’re invited to dinner CME. Or, join virtually!
May 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
IOL design mimics optic shape change of natural lens
August 1st 2003San Francisco-A novel accommodating IOL (FlexOptic, Quest Vision) designed to mimic the natural crystalline lens through an ability to change optic sphericity is a promising new alternative to treating presbyopia, with the potential for superior efficacy and safety relative to other options for surgical accommodative correction, said John D. Hunkeler, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Time-release drugs ease burden of drops
July 15th 2003San Francisco-Patient noncompliance can be overcome with the delivery of medication to the eye with intraocular time-release systems, according to James P. Gills, MD, who spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Silicone IOL well tolerated in high-risk glaucomatous eyes
July 1st 2003San Francisco-The ClariFlex third-generation silicone IOL (AMO) is well tolerated in high-risk glaucomatous eyes, and the Unfolder Silver-Z insertion system (AMO) performs well in these eyes, with a very low incidence of cartridge jams or damaged IOLs, accord-ing to Thomas W. Samuelson, MD.
Read More
IOL edge design helps to reduce capsulotomy rates at 1 year
July 1st 2003San Francisco-The Sensar IOL (AMO) with OptiEdge provides patients with excellent visual acuity, and after 1 year, it is associated with a higher incidence of clear posterior capsules and a lower rate of Nd:YAG capsulotomy compared with the parent model without OptiEdge, reported William J. Fishkind, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Blue-blocking lens performs like standard UV-absorbing model
July 1st 2003San Francisco-The AcrySof Natural IOL (Model SB30AL, Alcon), containing a covalently bonded, blue light-filtering chromophore (ImprUV), more closely mimics the light transmission spectrum of the precataractous adult human crystalline lens compared with standard UV-absorbing IOLs without any adverse effects on vision, said Paul H. Ernest, MD, at the American Society of Cata-ract and Refractive Surgery an-nual meeting.
Read More
Pseudoaccommodative IOL reduces aberration
July 1st 2003San Francisco-With its proprietary apodized diffractive technology, the AcrySof ReSTOR pseudoaccommodative IOL (Alcon) provides patients with excellent near and distance vision and only infrequently causes visual symptoms that are generally minimal and easily tolerated, said David Allen, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Bausch & Lomb to delay regulatory filing
June 15th 2003Rochester, NY-Bausch & Lomb will delay the regulatory filing for the intravitreal fluocinolone acetonide implant (Retisert), a treatment for diabetic macular edema (DME), for up to 3 years while the FDA reviews 12-month safety data of additional eyes treated with implants.
Read More
Temperature key to incidence of thermal burns during phaco
June 1st 2003The Legacy phacoemulsification system with AdvanTec (Alcon) runs cooler compared with the Sovereign phacoemulsification system with WhiteStar (Advanced Medical Optics) under all experimental conditions in air, according to Kevin M. Miller, MD.
Read More
Surgical correction of presbyopia in its infancy
June 1st 2003San Francisco-With the presbyopic population reaching 51% (141 million) in the United States, the interest in surgical correction of presbyopia will likely take off as the baby boomers look for alternatives to glasses, according to Richard L. Lindstrom, MD, who delivered the Binkhorst Lecture during the opening session of the American Society of Cataract and Refractive Surgery annual meeting.
Read More
Risks seen with silicone intracanalicular plugs
May 15th 2003Kansas City, MO-Placement of silicone intracanalicular plugs (ICP) in the treatment of dry eye can result in a variety of complications, including irreversible lacrimal occlusion. When removal is indicated, various surgical strategies may be necessary because the recommended simple irrigation in the office is not always effective, said William L. White, MD.
Read More
Being an oculoplastic surgeon is a deliberate choice
May 15th 2003Recently, I have heard oculoplastic surgeons voicing their concerns about the future of our profession. Many advise de-specializing to try to compete with other plastic surgeons. I advise trying to be the best in our area of expertise. We are privileged to be in the best specialty in medicine.
Read More
ICL effective treatment for moderate, high hyperopia
May 15th 2003San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul J. Dougherty, MD, who spoke during the American Society of Cataract and Refractive Surgery Annual Meeting.
Read More
Measure carefully to avoid punctum plug complications
May 15th 2003Many of the common complications associated with external silicone punctum plugs, such as extrusion or irritation, can be avoided if physicians take the time to measure the puncta and gauge the correct size, according to representatives of the major manufacturers of these plugs.
Read More
Exposures of porous orbital implants can be avoided
May 1st 2003In the past decade, porous orbital implants have become the implant of choice for many surgeons managing the anophthalmic socket after enucleation or evisceration. By permitting fibrovascular ingrowth, these porous implants are better able to resist infection, migration, and extrusion when compared with acrylic or silicone implants.
Read More
Advances in myectomy surgery give better cosmetic results
April 1st 2003Editor's Note: I developed myectomy surgery more than 25 years ago, and this procedure has been confirmed to be the best surgical treatment for blepharospasm. I have performed more than 1,000 myectomy procedures, and while functional results (reduction in spasm) have not changed greatly in the past few years, cosmetic results have improved greatly and negative side effects and healing time have been reduced.
Read More
Bimanual microphacoemulsification: the next phase?
March 15th 2003Cataract removal by means of phacoemulsification has improved over the last 35 years in small, incremental steps. The sequential introductions of capsulorhexis, foldable IOLs, clear corneal incisions, and topical anesthesia have made small improvements in the safety andefficacy of cataract surgery and as a whole have taken us one giant leap forward.Bimanual phacoemulsification is just another one of these small steps that may ultimately enhance our ability to offer the best surgical procedure to our patients.
Read More
Posterior chamber phakic IOLs appear safe for moderate, high myopia
March 15th 2003Orlando-Posterior chamber phakic implants can offer safe and effective correction of moderate to high myopia with stable refractive outcomes, low risks of operative and postoperative complications, high patient satisfaction, and the benefit of less induction of optical aberrations relative to LASIK, according to James J. Salz, MD.
Read More